Second Half Financial Partners LLC Sells 5,770 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Second Half Financial Partners LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 76.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,800 shares of the healthcare conglomerate's stock after selling 5,770 shares during the period. Second Half Financial Partners LLC's holdings in UnitedHealth Group were worth $911,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Howard Capital Management Group LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter valued at $341,000. Principal Financial Group Inc. raised its position in UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after purchasing an additional 180,479 shares during the last quarter. McIlrath & Eck LLC grew its holdings in shares of UnitedHealth Group by 8.2% during the third quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate's stock worth $371,000 after purchasing an additional 48 shares during the last quarter. SOA Wealth Advisors LLC. raised its holdings in UnitedHealth Group by 3.7% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 1,275 shares of the healthcare conglomerate's stock valued at $746,000 after buying an additional 46 shares during the last quarter. Finally, Tudor Financial Inc. acquired a new position in UnitedHealth Group in the 3rd quarter valued at approximately $900,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Down 2.8 %

NYSE UNH traded down $11.37 during trading hours on Thursday, hitting $400.07. The company's stock had a trading volume of 9,289,533 shares, compared to its average volume of 4,563,822. UnitedHealth Group Incorporated has a 52 week low of $399.53 and a 52 week high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company's 50-day simple moving average is $498.51 and its two-hundred day simple moving average is $531.25. The company has a market capitalization of $364.15 billion, a PE ratio of 25.81, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the previous year, the company posted $6.91 earnings per share. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.10%. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.

Wall Street Analyst Weigh In

UNH has been the topic of several analyst reports. Barclays reduced their price objective on shares of UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. KeyCorp decreased their target price on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Mizuho increased their price objective on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Finally, Erste Group Bank upgraded shares of UnitedHealth Group to a "strong-buy" rating in a report on Wednesday, April 16th. Three investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of $596.86.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.